Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial

  • Salvatore Micali Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy. http://orcid.org/0000-0002-6492-7820
  • Angelo Territo Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy.
  • Giacomo Maria Pirola Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy.
  • Nancy Ferrari Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy.
  • Maria Chiara Sighinolfi Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy.
  • Eugenio Martorana Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy.
  • Michele Navarra | mnavarra@unime.it Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Italy.
  • Giampaolo Bianchi Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia, Italy.

Abstract

Background and study objective: Several studies suggest a protective role of green tea catechins against prostate cancer (PCa). In order to evaluate the efficacy of green tea catechins for chemoprevention of PCa in patients with high-grade prostate intraepithelial neoplasia (HG-PIN) we performed a phase II clinical trial. Methods: Sixty volunteers with HG-PIN were enrolled to carry out a double-blind randomized placebo-controlled phase II clinical trial. Treated group took daily 600 mg of green tea catechins (Categ Plus®) for 1 year. Patients were screened at 6 and 12 months through prostatic biopsy and measurements of prostate-specific antigen (PSA). Results: Despite the statistically significant reduction of PSA observed in subjects who received green tea catechins for 6 and 12 months, we did not find any statistical difference in PCa incidence between the experimental groups neither after 6 nor after 12 months. However, throughout the one-year follow- up we observed very limited adverse effects induced by green tea catechins and a not significant improvement in lower urinary tract symptoms and quality of life. Conclusions: Although the small number of patients enrolled in our study and the relatively short duration of intervention, our findings seems to deny the efficacy of green tea catechins. However, results of our clinical study, mainly for its low statistical strength, suggest that the effectiveness of green tea catechins should be evaluated in both a larger cohort of men and longer trial.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biography

Salvatore Micali, Department of Urology, Bagiovara Hospital, University of Modena and Reggio Emilia
Professor at Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina
Published
2017-10-03
Info
Issue
Section
Original Papers - Prostate
Supporting Agencies
This clinical trial received no specific funding.
Keywords:
Prostate cancer, Green tea catechins, High-grade intra-epithelial neoplasia (HG-PIN), Herbal medicines, PSA, Complementary therapies
Statistics
  • Abstract views: 1337

  • PDF: 654
How to Cite
Micali, S., Territo, A., Pirola, G. M., Ferrari, N., Sighinolfi, M. C., Martorana, E., Navarra, M., & Bianchi, G. (2017). Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial. Archivio Italiano Di Urologia E Andrologia, 89(3), 197-202. https://doi.org/10.4081/aiua.2017.3.197